With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Compounded semaglutide has not gone through the same review process as FDA-approved drugs, so it is unclear how safe or effective these products are. It’s important to get a prescription for ...

Semaglutide was initially approved under the brand name Ozempic for Type 2 diabetes, while the brand name Wegovy is only approved for weight loss. Here, we’ll compare tirzepatide (Zepbound ...

Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ... on about 3,600 customer reviews, it has an A+ rating ...

The cohort study used data from the TriNetX database, encompassing patients diagnosed with diabetes and prescribed semaglutide between October 2019, and December 2023, with no history of NAION prior ...

Semaglutide 2.4 mg could prevent nearly 2 million major cardiac events and over 1 million deaths in eligible patients. Uptake of semaglutide remains low due to cost, supply issues, and payer ...